Calidi Biotherapeutics, Inc. (CLDI)
NYSEAMERICAN: CLDI · Real-Time Price · USD
0.8801
-0.0198 (-2.20%)
Oct 14, 2026, 10:58 AM EDT - Market open
Calidi Biotherapeutics Market Cap
Calidi Biotherapeutics has a market cap or net worth of $3.25 million as of October 14, 2026. It is the 46,493rd most valuable company in the world and the 6,235th biggest in the United States. Its market cap has decreased by 63.72% in one year.
Market Cap
3.25M
Enterprise Value
1.12M
1-Year Change
-63.72%
Global Rank
Country Rank
#6,235 United States
Category
ChartMarket Cap Chart
Since November 1, 2021, Calidi Biotherapeutics's market cap has decreased from $273.83M to $3.25M, a decrease of -98.81%. That is a compound annual growth rate of -59.14%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 14, 2026 | 3.25M | -62.02% |
| Dec 31, 2025 | 8.56M | -61.46% |
| Dec 31, 2024 | 22.21M | -58.52% |
| Dec 29, 2023 | 53.55M | -46.69% |
| Dec 30, 2022 | 100.45M | -64.38% |
| Dec 30, 2021 | 282.03M | 3.00% |
| Nov 1, 2021 | 273.83M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| PharmaCyte Biotech | 4.34M |
| Dermata Therapeutics | 4.10M |
| Ernexa Therapeutics | 3.92M |
| GRI Bio | 3.80M |
| Jupiter Neurosciences | 3.76M |
| Eocene | 3.69M |
| HCW Biologics | 3.58M |
| Addex Therapeutics | 3.56M |